Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|October 25, 2002
Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancerBarbara Bachtiary, Andreas Obermair, Bettina Dreier, et al.
Oral Oncology|October 7, 2011
Impact of elective neck dissection on regional recurrence and survival in cN0 staged oral maxillary squamous cell carcinomaPaul W Poeschl, Rudolf Seemann, Cornelia Czembirek, et al.
Cancer Biology & Therapy|September 14, 2006
Mcl-1 is a relevant molecular target for antisense oligonucleotide strategies in gastric cancer cellsVolker Wacheck, Daniel Cejka, Wolfgang Sieghart, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2011
Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximabEdgar Selzer, Susanne Liederer, Christiane Lemaire, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 15, 2009
The cyclooxygenase-2 inhibitor nimesulide, a nonsteroidal analgesic, decreases the effect of radiation therapy in head-and-neck cancer cellsCornelia Czembirek, Christina Eder-Czembirek, Boban M Erovic, et al.
Clinical Oral Investigations|May 31, 2012
Postoperative failure of platelet recovery is an independent risk factor for poor survival in patients with oral and oropharyngeal cancerChristos Perisanidis, Martina Mittlböck, Alexandra Schoppmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Mcl-1, vascular endothelial growth factor-R2, and 14-3-3sigma expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neckBoban M Erovic, Martina Pelzmann, Matthäus Ch Grasl, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology|September 4, 2012
Survival of patients with pathologic T0N+ oral and oropharyngeal cancer after neoadjuvant therapy and surgery: the minority reportChristos Perisanidis, Irene Sulzbacher, Martina Mittlböck, et al.
The British Journal of Oral & Maxillofacial Surgery|August 15, 2012
Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancerChristos Perisanidis, Fritz Wrba, Anita Brandstetter, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Improved survival in HPV/p16-positive oropharyngeal cancer patients treated with postoperative radiotherapyGregor Heiduschka, Anja Grah, Felicitas Oberndorfer, et al.
Pageof 8